How B12 Absorption Depends on Intrinsic Factor

Vitamin B12, also called cobalamin, is a water-soluble vitamin that the human body cannot synthesize on its own. It arrives exclusively through animal-derived foods or supplemental forms, and once it reaches the digestive tract, it faces one of the more elaborate absorption sequences among all the essential vitamins.

At the center of that sequence is a protein the stomach wall produces specifically to escort B12 into the small intestine. That protein — intrinsic factor — is so central to the process that its absence, regardless of how much B12 is consumed, renders normal absorption nearly impossible. Understanding what intrinsic factor does, and what disrupts it, explains why B12 status can decline even when dietary intake appears adequate.

The Step-by-Step Path B12 Takes From Stomach to Bloodstream

When food containing B12 enters the stomach, the vitamin is bound to proteins in the food matrix. Gastric acid and the enzyme pepsin begin breaking those food proteins apart, freeing B12 molecules into the stomach's acidic environment. At this stage, the liberated B12 does not immediately bind to intrinsic factor. Instead, it binds first to a group of proteins called haptocorrins (also known as R-proteins or transcobalamin I), which are secreted by salivary glands and the stomach lining. Haptocorrins protect B12 in the highly acidic stomach environment.

As the stomach contents move into the upper small intestine — the duodenum — pancreatic proteases break down the haptocorrin proteins, releasing B12 once more. It is at this point, in the more alkaline environment of the duodenum, that intrinsic factor takes over. Intrinsic factor, which has traveled from the stomach alongside the food bolus, binds B12 with high affinity to form a stable B12–intrinsic factor complex.

This complex travels the length of the small intestine until it reaches the terminal ileum, the final section of the small intestine. Specialized epithelial cells there display a receptor protein called cubam (a combination of two proteins, cubilin and amnionless). Cubam recognizes and binds the B12–intrinsic factor complex specifically, allowing the complex to be taken into the cell by receptor-mediated endocytosis. Once inside the epithelial cell, intrinsic factor is degraded and B12 is released, then transferred into the portal bloodstream bound to a transport protein called transcobalamin II, which carries it to tissues throughout the body.

A secondary, passive absorption pathway exists as well. Roughly 1–2% of a very large oral dose of B12 can cross the intestinal wall by simple diffusion, without intrinsic factor. This pathway is slow and inefficient but becomes clinically relevant in certain supplemental forms designed to deliver high doses.

The Compounds, Cells, and Organs That Make B12 Absorption Possible

Parietal cells of the stomach: These specialized cells in the gastric mucosa are the sole source of intrinsic factor. They also produce hydrochloric acid, which is necessary for the initial release of B12 from food proteins. Any condition or drug that reduces parietal cell function therefore affects both acid production and intrinsic factor output simultaneously.

Intrinsic factor itself: A glycoprotein with a molecular weight of roughly 45 kilodaltons, intrinsic factor is produced continuously by parietal cells and secreted into the stomach lumen. Its sole known biological function is to bind B12 and present it to the cubam receptor in the terminal ileum. Unlike many other nutrient-binding proteins, it is not recycled — it is degraded once the complex is internalized.

Haptocorrins (R-proteins): These binding proteins, secreted by salivary glands and the gastric mucosa, handle B12 first and protect it from the acidic stomach environment. They are not the absorption vehicle; they are a temporary carrier that must be removed before intrinsic factor can bind.

Pancreatic proteases: Enzymes such as trypsin, secreted by the pancreas into the duodenum, degrade the haptocorrins and allow the handoff to intrinsic factor. Pancreatic insufficiency can therefore interrupt B12 absorption at this transition point, even when intrinsic factor is present.

The terminal ileum: This segment of the small intestine is the only site where the cubam receptor is expressed in sufficient density for meaningful B12 uptake. Surgical removal of the terminal ileum — for example, in the management of certain bowel conditions — eliminates the primary absorption site entirely. Much like iron absorption relies on specific intestinal transporters that vary by form, B12 uptake is gated by a receptor present only in one anatomical location.

Transcobalamin II: Once B12 crosses the ileal epithelium, it binds to transcobalamin II in the bloodstream. This transport protein delivers B12 to cells throughout the body, where it enters via its own receptor-mediated uptake process. Inside cells, B12 is converted into its active coenzyme forms: methylcobalamin and adenosylcobalamin, which participate in methionine synthesis and fatty acid metabolism respectively.

Where B12 Absorption Breaks Down and Why It Is Often Overlooked

The most complete disruption of intrinsic factor–dependent absorption is pernicious anemia, an autoimmune condition in which the immune system produces antibodies that attack parietal cells, intrinsic factor itself, or both. When antibodies target intrinsic factor directly, they either block its B12-binding site or prevent the B12–intrinsic factor complex from docking with the cubam receptor. The result is severe B12 malabsorption that persists regardless of dietary B12 intake. Because the liver stores several years' worth of B12, symptoms of deficiency from pernicious anemia can take many years to appear, which contributes to delayed diagnosis.

Atrophic gastritis — a condition in which the gastric mucosa gradually thins, often associated with aging or Helicobacter pylori infection — reduces both acid secretion and intrinsic factor output. Reduced gastric acid impairs the initial release of protein-bound B12 from food, while reduced intrinsic factor limits the subsequent absorption step. This is why B12 insufficiency becomes more common with advancing age even in individuals consuming adequate amounts of animal protein.

Certain medications reduce gastric acid as their primary mechanism of action. Proton pump inhibitors and H2-receptor antagonists lower stomach acid to manage reflux and ulcers, but in doing so they also reduce the acid environment needed to free B12 from food. This is a recognized interaction documented in the medical literature, though its clinical significance depends on duration of use and individual baseline status.

Metformin, a medication widely used in blood glucose management, has been associated with reduced B12 absorption through a mechanism that appears to involve interference with the cubam receptor in the ileum, though the precise pathway is still under investigation.

Pancreatic exocrine insufficiency prevents adequate degradation of haptocorrins, so B12 remains bound to R-proteins and is never presented to intrinsic factor in the duodenum. This is a less commonly recognized route to B12 malabsorption but is well documented in individuals with chronic pancreatitis.

The friction points in B12 absorption contrast with those seen in other nutrients where the limiting factor is more straightforwardly chemical. Iron absorption, for instance, is strongly shaped by dietary compounds such as phytates and polyphenols that bind the mineral in the gut lumen. B12 absorption, by contrast, is gated primarily by a biological protein system that can be disrupted by autoimmunity, mucosal atrophy, or drug interactions rather than by food matrix chemistry alone.

What a Supplement Label Shows About B12 Form — and What It Cannot Show

Vitamin B12 appears on supplement labels in several chemical forms: cyanocobalamin, methylcobalamin, adenosylcobalamin, and hydroxocobalamin. The label is required to state the form and the quantity per serving, expressed in micrograms (mcg). The % Daily Value figure is calculated against the FDA's established reference intake for adults.

What the label cannot convey is how much of the stated amount will actually be absorbed by any given individual. Absorption depends entirely on the integrity of the intrinsic factor system described above. A label showing a large microgram quantity does not indicate that the full amount reaches the portal bloodstream; for someone with pernicious anemia, even a very large oral dose delivered through the intrinsic factor pathway will be absorbed poorly. The passive diffusion pathway becomes relevant only at extremely high doses, and even then the fraction absorbed remains small.

Third-party testing seals — such as those issued by independent verification organizations — confirm that the product contains what the label states and is free from specified contaminants. They do not assess how the product behaves inside the human body, and they make no statement about bioavailability in any individual. This mirrors the situation with other nutrients whose absorption varies substantially by individual physiology: magnesium absorption, for example, shifts significantly across its different chemical forms, yet no label can predict what proportion any one person will absorb.

No dietary supplement — including any B12 product — is FDA-approved before it reaches the market. Under the Dietary Supplement Health and Education Act (DSHEA), manufacturers are responsible for ensuring safety and accurate labeling, but the FDA does not evaluate or approve supplement products for efficacy prior to sale. Post-market surveillance and enforcement actions are the primary regulatory tools the FDA applies to this category.

Vitamin B12 absorption stands out among nutrients for the degree to which a single protein — intrinsic factor — controls access to the bloodstream. The pathway is elegant when intact and fragile when disrupted, and the liver's substantial storage capacity means that the consequences of disruption can remain invisible for years before they become measurable.

Note: This explains how supplements work. This statement has not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for advice from a physician, pharmacist, or registered dietitian.